相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting
Junya Sato et al.
SUPPORTIVE CARE IN CANCER (2020)
FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1
Preeti Narayan et al.
CLINICAL CANCER RESEARCH (2020)
Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study
Anna Ozaki et al.
TRIALS (2020)
The Association between Frailty and Abdominal Symptoms: A Hospital-based Cross-sectional Study
Daisuke Asaoka et al.
INTERNAL MEDICINE (2020)
An overview of acute gastrointestinal side effects of systemic anti-cancer therapy and their management
Padraic Smith et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2020)
Preventive effects of naldemedine, peripherally acting μ-opioid receptor antagonist, on morphine-induced nausea and vomiting in ferrets
Toshiyuki Kanemasa et al.
LIFE SCIENCES (2020)
Incidence of opioid-induced constipation in Japanese patients with cancer pain: A prospective observational cohort study
Akihiro Tokoro et al.
CANCER MEDICINE (2019)
American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation
Seth D. Crockett et al.
GASTROENTEROLOGY (2019)
A meta-analysis of naldemedine for the treatment of opioid-induced constipation
Xuesong Song et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer
N. Katakami et al.
ANNALS OF ONCOLOGY (2018)
Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial
Atsushi Nakajima et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
Kazuya Fukumura et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
Lynn R. Webster et al.
PAIN MEDICINE (2017)
Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: a randomized controlled clinical trial
Akiko Hanai et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity
Vanesa Stojanovska et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naive cancer patients: a propensity analysis
Marzia Lazzari et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Evolving paradigms in the treatment of opioid-induced bowel dysfunction
Jakob Lykke Poulsen et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)
Quality of Life and Healthcare Resource in Patients Receiving Opioids for Chronic Pain: A Review of the Place of Oxycodone/Naloxone
Bart Morlion et al.
CLINICAL DRUG INVESTIGATION (2015)
Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis
Camilo Rojas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Principles of Opioid Use in Cancer Pain
Russell K. Portenoy et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Validity and reliability of the Japanese version of the Patient Assessment of Constipation Quality of Life questionnaire
Haruka Nomura et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation
M. Camilleri et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study
P. Gisondi et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
New perspectives in the diagnosis and management of enteric neuropathies
Charles H. Knowles et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
A Multi-institutional Study Analyzing Effect of Prophylactic Medication for Prevention of Opioid-induced Gastrointestinal Dysfunction
Masashi Ishihara et al.
CLINICAL JOURNAL OF PAIN (2012)
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC
Augusto Caraceni et al.
LANCET ONCOLOGY (2012)
Opioid-Induced Constipation: Challenges and Therapeutic Opportunities
Michael Camilleri
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers
Kevin Smith et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Sodium Picosulfate in Patients With Chronic Constipation
Stefan Mueller-Lissner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Reduction of Opioid Side Effects by Prophylactic Measures of Palliative Care Team May Result in Improved Quality of Life
Michiaki Myotoku et al.
JOURNAL OF PALLIATIVE MEDICINE (2010)
Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain
A. K. Tuteja et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Gastrointestinal symptoms under opioid therapy: A prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine
Stefan Wirz et al.
EUROPEAN JOURNAL OF PAIN (2009)
The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)
Timothy J. Bell et al.
PAIN MEDICINE (2009)
Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
Alexander Stein et al.
Therapeutic Advances in Medical Oncology (2009)
Gastrointestinal side effects in chronic opioid users: results from a population-based survey
S. F. Cook et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Food intake and functional constipation: A cross-sectional study of 3,835 Japanese women aged 18-20 years
Kentaro Murakami et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2007)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire
P Marquis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist -: Results of a phase III, single-dose trial versus dolasetron
P Eisenberg et al.
CANCER (2003)
Effects of CP-99, 994, a tachykinin NK1 receptor antagonist, on abdominal afferent vagal activity in ferrets:: evidence for involvement of NK1 and 5-HT3 receptors
M Minami et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
分享论文
